e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Effects of air pollution on asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment options for air pollutant-driven airway disease
Sundeep Santosh Salvi (Pune (Maharashtra), India)
Source:
International Congress 2017 – Effects of air pollution on asthma and COPD
Session:
Effects of air pollution on asthma and COPD
Session type:
Symposium
Number:
4391
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sundeep Santosh Salvi (Pune (Maharashtra), India). Treatment options for air pollutant-driven airway disease. International Congress 2017 – Effects of air pollution on asthma and COPD
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Treatment of airway disease
Source: International Congress 2016 – Historical landmarks in respiratory medicine: contributions from the UK
Year: 2016
Air pollution and inflammatory airway disease: therapeutic options
Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=262
Year: 2002
Treatment of combined pulmonary fibrosis and emphysema
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Atomization inhalation on the NO content in the airway of patients with bronchial asthma
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016
Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Poor adherence to ICS treatment in patients with chronic respiratory diseases
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?
Source: Eur Respir J 2015; 46: 287-288
Year: 2015
Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Measuring adherence to therapy in airways disease
Source: Breathe, 17 (2) 210037; 10.1183/20734735.0037-2021
Year: 2021
Small airway disease and tidal airway closure in end-stage liver disease patients
Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases
Year: 2009
Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Cost-effectiveness of bronchial thermoplasty (BT) treatment relative to no BT treatment option for patients with severe asthma
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014
Are ultrafine particle inhalers, better for patients with small airway involvement?
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020
Management of chronic airway infection in bronchiectasis
Source: Virtual Congress 2020 – The future of bronchiectasis management
Year: 2020
Poverty cannot be inhaled and it is not a genetic condition. How can it be associated with chronic airflow obstruction?
Source: Eur Respir J, 49 (6) 1700823; 10.1183/13993003.00823-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept